Ac Immune Stock Buy Hold or Sell Recommendation
| ACIU Stock | USD 2.36 0.02 0.84% |
Given the investment horizon of 90 days and your complete indifference towards market risk, our recommendation regarding AC Immune is 'Strong Hold'. Macroaxis provides AC Immune buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ACIU positions. The advice algorithm takes into account all of AC Immune's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting AC Immune's buy or sell advice are summarized below:
Real Value 4.53 | Target Price 11.08 | Hype Value 2.06 | Market Value 2.36 | Naive Value 2.34 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell AC Immune given historical horizon and risk tolerance towards AC Immune. When Macroaxis issues a 'buy' or 'sell' recommendation for AC Immune, the advice is generated through an automated system that utilizes algorithms and statistical models.
ACIU |
Execute AC Immune Buy or Sell Advice
The ACIU recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on AC Immune. Macroaxis does not own or have any residual interests in AC Immune or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute AC Immune's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Very Weak | Details | |
Volatility | Unstable | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
AC Immune Trading Alerts and Improvement Suggestions
| AC Immune generated a negative expected return over the last 90 days | |
| AC Immune has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 14.8 M. Net Loss for the year was (54.23 M) with loss before overhead, payroll, taxes, and interest of (56.4 M). | |
| AC Immune currently holds about 154.15 M in cash with (60.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.83. | |
| Roughly 42.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: AC Immune Reports Q2 Loss, Lags Revenue Estimates - Yahoo Movies Canada |
AC Immune Returns Distribution Density
The distribution of AC Immune's historical returns is an attempt to chart the uncertainty of AC Immune's future price movements. The chart of the probability distribution of AC Immune daily returns describes the distribution of returns around its average expected value. We use AC Immune price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of AC Immune returns is essential to provide solid investment advice for AC Immune.
| Mean Return | -0.79 | Value At Risk | -8.52 | Potential Upside | 7.01 | Standard Deviation | 4.56 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of AC Immune historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
ACIU Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as AC Immune is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading AC Immune backward and forwards among themselves. AC Immune's institutional investor refers to the entity that pools money to purchase AC Immune's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Handelsbanken Fonder Ab | 2023-12-31 | 101.1 K | Dimensional Fund Advisors, Inc. | 2023-12-31 | 59.8 K | Banque Cantonale Vaudoise | 2023-12-31 | 54.8 K | Ubs Group Ag | 2023-12-31 | 45 K | Geode Capital Management, Llc | 2023-12-31 | 40.9 K | Goldman Sachs Group Inc | 2023-12-31 | 34.6 K | Fmr Inc | 2023-12-31 | 27.2 K | Royal Bank Of Canada | 2023-12-31 | 13.4 K | Watch Point Trust Co | 2023-12-31 | 12.8 K | Bvf Inc | 2023-09-30 | 7.4 M | Avidity Partners Management Lp | 2023-12-31 | 4.5 M |
AC Immune Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 37.1M | (32.7M) | (78.7M) | (50.6M) | 46.9M | 49.3M | |
| Depreciation | 1.7M | 2.0M | 2.4M | 2.4M | 2.2M | 1.3M | |
| Capital Expenditures | 1.9M | 1.7M | 2.6M | 1.2M | 801K | 1.3M | |
| Net Income | 45.4M | (61.9M) | (73.0M) | (70.8M) | (54.2M) | (51.5M) | |
| End Period Cash Flow | 193.6M | 160.9M | 82.2M | 31.6M | 78.5M | 107.1M | |
| Change To Netincome | 2.4M | 5.0M | (1.9M) | 3.3M | 3.7M | 3.9M | |
| Investments | (66.9M) | 30M | (53.7M) | 23.8M | 65.6M | 68.9M | |
| Net Borrowings | 50.1M | (946K) | 23.0M | (569K) | (654.4K) | (621.6K) | |
| Free Cash Flow | 53.3M | (61.2M) | (68.3M) | (74.8M) | (61.2M) | (58.1M) | |
| Other Non Cash Items | (909K) | 551K | (6.2M) | (72K) | 1.1M | 1.2M |
AC Immune Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to AC Immune or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that AC Immune's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a ACIU stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.87 | |
β | Beta against NYSE Composite | 1.18 | |
σ | Overall volatility | 4.66 | |
Ir | Information ratio | -0.19 |
AC Immune Volatility Alert
AC Immune exhibits very low volatility with skewness of 0.24 and kurtosis of -0.08. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure AC Immune's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact AC Immune's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.AC Immune Fundamentals Vs Peers
Comparing AC Immune's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze AC Immune's direct or indirect competition across all of the common fundamentals between AC Immune and the related equities. This way, we can detect undervalued stocks with similar characteristics as AC Immune or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of AC Immune's fundamental indicators could also be used in its relative valuation, which is a method of valuing AC Immune by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare AC Immune to competition |
| Fundamentals | AC Immune | Peer Average |
| Return On Equity | -0.33 | -0.31 |
| Return On Asset | -0.18 | -0.14 |
| Operating Margin | (0.24) % | (5.51) % |
| Current Valuation | 127.82 M | 16.62 B |
| Shares Outstanding | 98.9 M | 571.82 M |
| Shares Owned By Insiders | 41.87 % | 10.09 % |
| Shares Owned By Institutions | 30.23 % | 39.21 % |
| Number Of Shares Shorted | 560.59 K | 4.71 M |
| Price To Earning | (16.96) X | 28.72 X |
| Price To Book | 1.55 X | 9.51 X |
| Price To Sales | 18.31 X | 11.42 X |
| Revenue | 14.8 M | 9.43 B |
| Gross Profit | (56.4 M) | 27.38 B |
| EBITDA | (50.37 M) | 3.9 B |
| Net Income | (54.23 M) | 570.98 M |
| Cash And Equivalents | 154.15 M | 2.7 B |
| Cash Per Share | 1.83 X | 5.01 X |
| Total Debt | 3.5 M | 5.32 B |
| Debt To Equity | 0.01 % | 48.70 % |
| Current Ratio | 13.28 X | 2.16 X |
| Book Value Per Share | 1.71 X | 1.93 K |
| Cash Flow From Operations | (60.41 M) | 971.22 M |
| Short Ratio | 3.18 X | 4.00 X |
| Earnings Per Share | (0.70) X | 3.12 X |
| Target Price | 10.51 | |
| Number Of Employees | 133 | 18.84 K |
| Beta | 1.01 | -0.15 |
| Market Capitalization | 235.38 M | 19.03 B |
| Total Asset | 182.81 M | 29.47 B |
| Retained Earnings | (316.2 M) | 9.33 B |
| Working Capital | 111.58 M | 1.48 B |
| Current Asset | 160 M | 9.34 B |
| Current Liabilities | 11 M | 7.9 B |
AC Immune Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as ACIU . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 22901.28 | |||
| Daily Balance Of Power | (0.11) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 2.4 | |||
| Day Typical Price | 2.39 | |||
| Price Action Indicator | (0.05) | |||
| Period Momentum Indicator | (0.02) |
About AC Immune Buy or Sell Advice
When is the right time to buy or sell AC Immune? Buying financial instruments such as ACIU Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 16.7M | 9.4M | 11.1M | 9.5M | Total Assets | 261.4M | 185.9M | 182.8M | 177.6M |
Use Investing Ideas to Build Portfolios
In addition to having AC Immune in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Government Funds Thematic Idea Now
Government Funds
Funds or Etfs that invest in fixed income securities issued by national government to finance government spending or to facilitate Federal Reserve monetary policies. The Government Funds theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Government Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out AC Immune Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy ACIU Stock please use our How to Invest in AC Immune guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for ACIU Stock analysis
When running AC Immune's price analysis, check to measure AC Immune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AC Immune is operating at the current time. Most of AC Immune's value examination focuses on studying past and present price action to predict the probability of AC Immune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AC Immune's price. Additionally, you may evaluate how the addition of AC Immune to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
Is AC Immune's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AC Immune. If investors know ACIU will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AC Immune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.70) | Revenue Per Share 0.175 | Quarterly Revenue Growth 14.8 K | Return On Assets (0.18) | Return On Equity (0.33) |
The market value of AC Immune is measured differently than its book value, which is the value of ACIU that is recorded on the company's balance sheet. Investors also form their own opinion of AC Immune's value that differs from its market value or its book value, called intrinsic value, which is AC Immune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AC Immune's market value can be influenced by many factors that don't directly affect AC Immune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AC Immune's value and its price as these two are different measures arrived at by different means. Investors typically determine if AC Immune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AC Immune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.